Luteal Function in the Bitch: Changes during Diestrus in Pituitary Concentration of and the Number of Luteal Receptors for Luteinizing Hormone and Prolactin1
Abstract:The concentration of unoccupied luteal receptors for luteinizing hormone (LH) and prolactin, and the concentration of these two hormones in the pituitary was determined in 11 groups of bitches (n = 3 or 4/group) representing stages from proestrus through Day 80 of diestrus. Despite dramatic changes in serum concentrations of progesterone, the concentration of luteal receptors for LH and prolactin was quite constant throughout the entire luteal phase. In association with the ovulatory surge of LH, pituitary con… Show more
“…This suggests that prolactin functions as the main luteotrophic factor in the cyclic dog during the second half of the luteal period. This conclusion is supported by the observation of Fernandes et al (7), that receptors for prolactin are more numerous than for LH in the dog.…”
Section: Discussionsupporting
confidence: 65%
“…Concentrations of receptors for LH and prolactin in the corpus luteum are quite constant throughout the entire luteal phase (7).…”
SUMMARY The role of prolactin and LH in the control of the function of the corpus luteum in the dog was studied. Experiments were performed to interfere with the secretion of a) prolactin by administering a dopamine agonist and b) LH by desensitisation with a long-acting LHRH and by stimulation. Treatments with prolactin-lowering dosages of bromocriptine, (20 pg/kg body weight twice a day, orally; n = 8) which started between day 1-5 (n = 4) and day 20-24 (n = 4) of the luteal period resulted in a similar pattern of progesterone concentration in peripheral blood in both groups. The progesterone release in the second half of the luteal period (13. I ± 1.8% (sem) of the progesterone release of the total luteal period) was significantly lower than in control dogs (24.7 ± 2.2%). Treatment at about day 30 of the luteal period with LHRH CR (1.34 mg, intramuscularly; n = 3), which significantly suppressed the LH level, did not reduce the progesterone release in the second half of the luteal period, 21.3 ± 4.7% compared to 24.7 ± 2.2% in the control dogs. The endogenous LH peak resulting from treatment with LHRH had no effect on the progesterone concentration in the blood. It is concluded that prolactin is the main luteotrophic factor in the cyclic dog during the second half of the luteal period.
“…This suggests that prolactin functions as the main luteotrophic factor in the cyclic dog during the second half of the luteal period. This conclusion is supported by the observation of Fernandes et al (7), that receptors for prolactin are more numerous than for LH in the dog.…”
Section: Discussionsupporting
confidence: 65%
“…Concentrations of receptors for LH and prolactin in the corpus luteum are quite constant throughout the entire luteal phase (7).…”
SUMMARY The role of prolactin and LH in the control of the function of the corpus luteum in the dog was studied. Experiments were performed to interfere with the secretion of a) prolactin by administering a dopamine agonist and b) LH by desensitisation with a long-acting LHRH and by stimulation. Treatments with prolactin-lowering dosages of bromocriptine, (20 pg/kg body weight twice a day, orally; n = 8) which started between day 1-5 (n = 4) and day 20-24 (n = 4) of the luteal period resulted in a similar pattern of progesterone concentration in peripheral blood in both groups. The progesterone release in the second half of the luteal period (13. I ± 1.8% (sem) of the progesterone release of the total luteal period) was significantly lower than in control dogs (24.7 ± 2.2%). Treatment at about day 30 of the luteal period with LHRH CR (1.34 mg, intramuscularly; n = 3), which significantly suppressed the LH level, did not reduce the progesterone release in the second half of the luteal period, 21.3 ± 4.7% compared to 24.7 ± 2.2% in the control dogs. The endogenous LH peak resulting from treatment with LHRH had no effect on the progesterone concentration in the blood. It is concluded that prolactin is the main luteotrophic factor in the cyclic dog during the second half of the luteal period.
“…Serum concentrations of PRL remain mostly low during the first half of pregnancy, at approximately 5-6 weeks of gestation they begin to increase constantly towards parturition [14]. In non-pregnant animals serum concentrations of PRL remain low during most of the course of dioestrus and increase 2 to 3 fold around day 50 post ovulation, which is the time when parturition would have occurred [7,14,15]. Similarly, an increased availability of the luteinizing hormone (LH) has been observed in bitches when P4 concentrations were declining during the course of dioestrus [6,16].…”
Section: Introductionmentioning
confidence: 99%
“…As for the dog, and concerning the presence of PRLr in canine reproductive tissues, Fernandes et al [15] reported about the concentrations of the binding sites for prolactin in the luteal membranes isolated from tissue homogenates obtained from non-pregnant dogs during the course of dioestrus. They tended to be maximal during the first 40 days of the luteal life-span and were generally lower thereafter, when serum and luteal concentrations of P4 were decreasing [15].…”
Section: Introductionmentioning
confidence: 99%
“…They tended to be maximal during the first 40 days of the luteal life-span and were generally lower thereafter, when serum and luteal concentrations of P4 were decreasing [15]. Concomitantly with the decrease of peripheral P4 levels a decrease in expression of the steroidogenic acute regulatory protein (StAR) occurs [9,35].…”
BackgroundEndocrine mechanisms governing canine reproductive function remain still obscure. Progesterone (P4) of luteal origin is required for maintenance of pregnancy. Corpora lutea (CL) are gonadotrop-independent during the first third of dioestrus; afterwards prolactin (PRL) is the primary luteotropic factor. Interestingly, the increasing PRL levels are accompanied by decreasing P4 concentrations, thus luteal regression/luteolysis occurs in spite of an increased availability of gonadotropic support. PRL acts through its receptor (PRLr), the expression of which has not yet been thoroughly investigated at the molecular and cellular level in the dog.MethodsThe expression of PRLr was assessed in CL of non-pregnant dogs during the course of dioestrus (days 5, 15, 25, 35, 45, 65 post ovulation; p.o.) as well as in CL, the utero/placental compartments (Ut/Pl) and interplacental free polar zones (interplacental sites) from pregnant dogs during the pre-implantation, post-implantation and mid-gestation period of pregnancy and during the normal and antigestagen-induced luteolysis. Expression of PRLr was tested by Real Time PCR, immunohistochemistry and in situ hybridization.ResultsIn non-pregnant CL the PRLr expression was significantly upregulated at day 15 p.o. and decreased significantly afterwards, towards the end of dioestrus. CL of pregnancy showed elevated PRLr expression until mid gestation while prepartal downregulation was observed. Interestingly, placental but not interplacental expression of PRLr was strongly time-related; a significant upregulation was observed towards mid-gestation. Within the CL PRLr was localized to the luteal cells; in the Ut/Pl it was localized to the fetal trophoblast and epithelial cells of glandular chambers. Moreover, in mid-pregnant animals treated with an antigestagen, both the luteal and placental, but not the uterine PRLr were significantly downregulated.ConclusionsThe data presented suggest that the luteal provision of P4 in both pregnant and non-pregnant dogs may be regulated at the PRLr level. Furthermore, a role of PRL not only in maintaining the canine CL function but also in regulating the placental function is strongly suggested. A possible functional interrelationship between luteal P4 and placental and luteal PRLr expression also with respect to the prepartal luteolysis is implied.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.